×

Do you want to link to this External Site and leave Amgen.co.uk?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this Amgen Site outside the UK and leave Amgen.co.uk?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Please note, this page is intended for UK healthcare professionals. By clicking to enter this page you are confirming that you are a UK healthcare professional.

×

Do you want to link to this Amgen Site and leave Amgen.co.uk?

Please note this site is only intended for UK Healthcare professionals and UK patients that have been prescribed Prolia®

YOU ARE NOW LEAVING THIS WEBSITE.

Disclosures

Amgen Limited and Amgen Ireland Limited are committed to fully complying with the disclosure requirements of the ABPI Code of Practice for the Pharmaceutical Industry and the IPHA Code of Practice for the Pharmaceutical Industry respectively.

In This Section

  • Joint Working Initiatives

    Amgen’s Joint Working Initiatives are projects implemented under an agreement with the NHS to address shared goals in relation to health systems and patient care.

  • Patient Advocacy Group Funding

    This includes information on our work with patient advocacy groups including details of the level of funding provided.

  • Transfer of Value Disclosure to HCPs, HCOs and R&D

    We disclose payments we make to healthcare professionals, healthcare and other organisations and in research work such as clinical trials, non-clinical studies and non-interventional studies.